, However, Jeremy Rifkin claims that "genetically altered human embryos and fetuses as well as human genes, cell lines, tissues, and organs are potentially patentable, leaving open the possibility of patenting all of the separate parts, if not the whole, of a human being, pp.44-45
, Just to prove Shatz's point, the onco-mouse was originally refused a patent by the EPO, but this was reversed in 1992, and, more generally, p.452, 1997.
, , p.412
, , p.412
, For a more sceptical view of this decision see (Sagoff, pp.434-440, 1980.
, 189 F. 95 (SDNY 1911)
Quoted In Ossorio, p.413 ,
, , p.411
Available on the web at if we suppose that such a utilitarian justification would operate against a background of moral and legal rights precluding such things as theft and forced labour, p.409 ,
the law seems to reward results, not contributions and efforts, and Resnik p, vol.4, p.408 ,
concerning what may be a substantial difference between the socially optimal rate of invention and the maximal rate of invention, p.409 ,
, At p. 2 Shulman notes of the USPTO that "despite its size, age and pedigree, the agency must surely rank as one of the least-known agencies of the U.S. government", he also expresses widespread doubts about the ability of the USPTO to interpret its criteria for awarding patents
, In 1996 the US Congress considered a measure, the Ganske-Wyden Bill 9Hr1137) that would have prevented the PTO from awarding patents that do not involve a new machine or compound". This, so it seems, 2000.
, In 1991, the patent office was cut off from general tax revenues and required to subsist entirely on 26 fees from its operating budget. The political argument was that customers should pay for government services. Thus, officials think of their fee-paying applicants as their customers: the more the better". (Emphasis in the text). Gleick says, However, this would have no obvious effect on the "capture" of the PTO by companies pursuing patents, on whom the Office frequently depends both for expertise and for revenues, pp.198-90, 1997.
Life Forms, the Law and Profits, 1998. ,
The Morality of Patenting, Biotechnology, Patents and Morality, pp.219-223, 1997. ,
The Patenting of DNA, Science, vol.280, 1998. ,
, Biological and Social Issues in Biotechnology Sharing, 1998.
DNA Music: Intellectual Property and the Law of Unintended Consequences' Science Studies, vol.18, pp.5-29, 2005. ,
, Sovereign Virtue, 2002.
Unnatural Selection: Technology, Politics and Plant Evolution, 1994. ,
Can Patents Deter Innovation? The Anticommons in Biomedical Research, p.280, 1998. ,
, Contemporary Political Philosophy: An Introduction, 1990.
The Consequences of Modern Genetic Engineering: Patents, "Nomads" and the "Bio-Industrial Compex, The Social Management of Genetic Engineering, 1998. ,
, Ashgate Publishing Ltd) ch, vol.18
, The Case for And Against the Patenting of Biotchnological Inventions' in Siegrid Sterckx (ed) Biotechnology, Patents and Morality, pp.185-201, 1997.
A Companion to Genethics: Philosophy and the Genetic Revolution, pp.438-454, 2002. ,
Legal and Ethical Issues in Patenting Human DNA, 2002. ,
A Companion to Genethics: Philosophy and the Genetic Revolution, pp.408-427 ,
The Morality of Human Gene Patents, 1997. ,
The Biotech Century: Harnessing the Gene and Remaking the World, 1998. ,
A Companion to Genethics: Philosophy and the Genetic Revolution, pp.420-437, 2002. ,
, Patents and Morality' in S. Sterckx (ed) Biotechnology, Patents and Morality, pp.160-166
, Technology Review, p.7, 1995.
Biotechnology Patents in Europe: From Law to Ethics, Biotechnology, Patents and Morality, pp.139-148, 1997. ,
The Moral Status of the Gene, A Companion to Genethics: Philosophy and the Genetic Revolution, 2002. ,
95 (SDNY 1911) Discussion Papers The Nuffield ld Council of, The Ethics of Patenting DNA : A Discussion Paper, vol.189, pp.6-9, 2002. ,
Patently Absurd' The New York Times Magazine , Section 6, pp.44-49, 2002. ,
The Lords of Creation' Prospect Magazine, vol.32, p.12, 1998. ,